BGN and osteoporosis: By the observation that biglycan-deficient mice display an osteoporosis-likephenotype, biglycan was discovered to be the first non-collageneous matrix component foundin bone, being a regulator of bone formation and mass (Xu et al. 1998; Young et al. 2002).